Division of Pathophysiology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan.
Cancer Sci. 2018 Aug;109(8):2458-2468. doi: 10.1111/cas.13660. Epub 2018 Jul 16.
Heterogeneous nuclear ribonucleoprotein L-like (HNRNPLL), an RNA-binding protein that regulates alternative splicing of pre-mRNA, has been shown to regulate differentiation of lymphocytes, as well as metastasis of colorectal cancer cells. Here, we show that HNRNPLL promotes cell cycle progression and, hence, proliferation of colorectal cancer cells. Functional annotation analysis of those genes whose expression levels were changed threefold or more in RNA sequencing analysis between SW480 cells overexpressing HNRNPLL and those knocked down for HNRNPLL revealed enrichment of DNA replication-related genes by HNRNPLL overexpression. Among 13 genes detected in the DNA replication pathway, PCNA, RFC3 and FEN1 showed reproducible upregulation by HNRNPLL overexpression both at mRNA and at protein levels in SW480 and HT29 cells. Importantly, knockdown of any of these genes alone suppressed the proliferation-promoting effect induced by HNRNPLL overexpression. RNA-immunoprecipitation assay presented a binding of FLAG-tagged HNRNPLL to mRNA of these genes, and HNRNPLL overexpression significantly suppressed the downregulation of these genes during 12 h of actinomycin D treatment, suggesting a role of HNRNPLL in mRNA stability. Finally, analysis of a public RNA sequencing dataset of clinical samples suggested a link between overexpression of HNRNPLL and that of PCNA, RFC3 and FEN1. This link was further supported by immunohistochemistry of colorectal cancer clinical samples, whereas expression of CDKN1A, which is known to inhibit the cooperative function of PCNA, RFC3 and FEN1, was negatively associated with HNRNPLL expression. These results indicate that HNRNPLL stabilizes mRNA encoding regulators of DNA replication and promotes colorectal cancer cell proliferation.
异质核核糖核蛋白 L 样(HNRNPLL)是一种 RNA 结合蛋白,可调节前体 mRNA 的可变剪接,已被证明可调节淋巴细胞的分化以及结直肠癌细胞的转移。在这里,我们表明 HNRNPLL 促进结直肠癌细胞的细胞周期进程,从而促进增殖。在过表达 HNRNPLL 的 SW480 细胞与敲低 HNRNPLL 的 SW480 细胞之间的 RNA 测序分析中,那些表达水平变化三倍或更多的基因的功能注释分析显示,HNRNPLL 过表达导致 DNA 复制相关基因富集。在 DNA 复制途径中检测到的 13 个基因中,PCNA、RFC3 和 FEN1 在 SW480 和 HT29 细胞中均在 mRNA 和蛋白水平上显示出 HNRNPLL 过表达的可重复上调。重要的是,单独敲低这些基因中的任何一个都能抑制 HNRNPLL 过表达诱导的增殖促进作用。RNA 免疫沉淀分析显示 FLAG 标记的 HNRNPLL 与这些基因的 mRNA 结合,并且 HNRNPLL 过表达在放线菌素 D 处理 12 小时内显著抑制这些基因的下调,表明 HNRNPLL 在 mRNA 稳定性中起作用。最后,对临床样本的公共 RNA 测序数据集的分析表明 HNRNPLL 的过表达与 PCNA、RFC3 和 FEN1 的过表达之间存在关联。免疫组化分析结直肠癌症临床样本进一步支持了这一关联,而 CDKN1A 的表达与 PCNA、RFC3 和 FEN1 的协同功能抑制相关,与 HNRNPLL 的表达呈负相关。这些结果表明,HNRNPLL 稳定编码 DNA 复制调节剂的 mRNA,并促进结直肠癌细胞增殖。